ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CPLX2 Regulates Ferroptosis and Apoptosis Through NRF2 Pathway in Human Hepatocellular Carcinoma Cells

Li, Hui; Zhao, Juan*; Zhong, Xiao-lan; Xu, Pei-yan; Du, Li-jun; Fang, Ping; Tan, Li-juan; Li, Mei-juan; Zhang, Cheng-fang; Cao, Tian-sheng*南方医科大学
Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology2023-1DOI: 10.1007/s12010-022-04135-9
8被引4阅读
引用收藏
分享

摘要

Understanding the principle of regulated cell death (RCD) such as ferroptosis and apoptosis provides opportunities to overcome sorafenib resistance of HCC. Complexin II (CPLX2) is involved in calcium-dependent fusion of vesicles and plasma membrane, and recent studies showed CPLX2 is involved in cancer progression. However, the expression and function of CPLX2 are unclear in hepatocellular carcinoma (HCC). qPCR and western blotting assays were used to detect the levels of CPLX2. MTT and colony formation assays were used to detect cell viability. The contents of iron, ROS, MDA, and GSH were used to evaluate the function of CPLX2 on ferroptosis, while the flow cytometry and TUNEL assays were used to evaluate the role of CPLX2 on apoptosis. Our analysis showed CPLX2 is significantly upregulated in HCC, which predicts poor overall survival (OS), progression-free survival (PFS), relapse-free survival (RFS), and disease-specific survival (DSS) for patients with HCC. Further function enrichment analysis of genes related to CPLX2 showed CPLX2 is involved in the NRF2 pathway. Downregulation of CPLX2 can inhibit NRF2 expression and the transcription of its downstream genes, which confirms that CPLX2 is involved in NRF2 pathway. Cell viability assay showed that ferroptosis and apoptosis inhibitors can reverse the inhibition effect of CPLX2-knockdown on cell survival, respectively. And downregulation of CPLX2 significantly promotes the contents of iron, ROS, and MDA, while inhibiting the GSH level of HCC cell lysate, suggesting CPLX2 involved in ferroptosis. Moreover, downregulation of CPLX2 promotes the apoptosis of HCC cells by flow cytometry and TUNEL assay. And upregulation of NRF2 can partly reverse the inhibitory effect of CPLX2-downregulation on ferroptosis and apoptosis. Finally, we found downregulation of CPLX2 aggravates cell death induced by sorafenib. CPXL2 regulates ferroptosis and apoptosis through NRF2 pathway, and CPLX2 knockdown promotes cell death induced by sorafenib. CPLX2 might be an effective target for therapy patients with HCC.

学科与关键词

关键词
SorafenibCPLX2NRF2ApoptosisFerroptosis
相关
加载中…
  • Downregulation of MCF2L Promoted the Ferroptosis of Hepatocellular Carcinoma Cells through PI3K/mTOR Pathway in a RhoA/Rac1 Dependent Manner
    Huang, Si-cong; Chen, Yi-mei; Hu, Ying-yu; Shi, Yong-jie; Xiao, Qi-wen; Li, Zhe; Kang, Jia-le; Zhou, Qiang; Shen, Gang*; Jia, Hong-yun*DISEASE MARKERS, 2022, 2022: 6138941.被引 3
  • Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
    Huang, Ziyue; Xia, Haoming; Cui, Yunfu; Yam, Judy Wai Ping*; Xu, Yi*Journal of Clinical and Translational Hepatology, 2023, 11(1): 207-218.被引 10
  • Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
    Xiao, Youmei; Xu, Zhanxue; Cheng, Yuan; Huang, Rufan; Xie, Yuan; Tsai, Hsiang-i; Zha, Hualian; Xi, Lifang; Wang, Kai; Cheng, Xiaoli; Gao, Yanfeng; Zhang, Changhua*; Cheng, Fang*; Chen, Hongbo*BIOMATERIALS RESEARCH, 2023, 27(1): 63.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology
发表日期
2023-01
卷期
第 195 卷, 第 1 期
页码
597-609
DOI
10.1007/s12010-022-04135-9
语言
ENGLISH
成果收录
SCIE
资助标注
Science and Technology Plan Project of Guangzhou [202002030044]; Fund of Affiliated Huadu Hospital, Southern Medical University (People's Hospital of Huadu District) [2020B03]

作者

  • L

    Li, Hui (第一作者)

    southern med univ

  • Z

    Zhao, Juan (通讯)

    southern med univ

查看全部 10 位作者收起作者
  • Z

    Zhong, Xiao-lan

    southern med univ

  • X

    Xu, Pei-yan

    southern med univ

  • D

    Du, Li-jun

    southern med univ

  • F

    Fang, Ping

    southern med univ

  • T

    Tan, Li-juan

    southern med univ

  • L

    Li, Mei-juan

    southern med univ

  • Z

    Zhang, Cheng-fang

    southern med univ

  • C

    Cao, Tian-sheng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417